Accredited E-Learning Program Available NOW.

The following program was developed with the leadership of a Thrombosis Canada Scientific Steering Committee

Click this link to register and participate in our e-learning program:  ENTER

Français ici

 

Program Description:

Primary Thromboprophylaxis in Ambulatory Cancer Patients

Scientific Steering Committee:

Marc Carrier, MD, MSc, FRCPC (Chair)
Hematologist
Ottawa, Ontario

Peter Gross, MD, MSc, FRCPC
Internal Medicine
Hamilton, Ontario

Eric Tseng, MD, MScCH, FRCPC
Hematologist
Toronto, Ontario

Cynthia Wu, MD, FRCPC
Hematologist
Edmonton, Alberta

Objectives:

1. Identify which ambulatory cancer patients are at high risk of venous thromboembolism (VTE)
2. Describe the rationale for primary thromboprophylaxis in ambulatory cancer patients
3. Apply data from recent clinical trials in clinical decision-making about primary thromboprophylaxis

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Ottawa’s Office of Continuing Professional Development. You may claim a maximum of 0.5 hours (credits are automatically calculated).

La présente activité est une activité d’apprentissage collectif agréée (section 1), au sens que lui donne le programme de Maintien du certificat du Collège royal des médecins et chirurgiens du Canada; elle a été approuvée par le Bureau de formation professionnelle continue de l’Université d’Ottawa. Vous pouvez déclarer un maximum de 0,5 heures (les crédits sont calculés automatiquement).

Click here to access the program:  ENTER

This program provided with support by an unrestricted education grant from the BMS-Pfizer Alliance